NEO
NeoGenomics, Inc. (NEO) Investor Questions
Review NeoGenomics, Inc. (NEO) faq with server-rendered company data, supporting context and links to related investor research.
- Company
- NeoGenomics, Inc.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Overall BTI score
- 65
- Annual revenue
- $727.33M
- Annual net income
- $-108.03M
- Annual free cash flow
- $-21.78M
NeoGenomics, Inc. (NEO) Investor Questions research
NeoGenomics, Inc. trades under the ticker NEO. The company is classified in the Healthcare sector and the Medical - Diagnostics & Research industry.
Investors commonly review NEO through its earnings trend, revenue, free cash flow, balance sheet, valuation and historical risk. The linked research sections provide a separate crawlable page for each data-rich topic.